Daniel A. Heller: Featured News

Daniel A. Heller: Featured News

Share
Share
Education
MSK scientists Daniel Heller and Kayvan Keshari with a confocal microscope.
MSK’s Cancer Engineering Focus Draws Top Scientists
Learn how a new cancer engineering PhD program is attracting leading scientists to come to MSK.
Education
MSK biochemist and imaging specialist Kayvan Keshari and biomedical engineer Daniel Heller.
A New Breed of Cancer Fighters
Read about a first-of-its kind PhD program that enables aspiring scientists to tackle tough cancer problems.
SKI biomedical engineer Dr. Daniel Heller
Getting Drugs Across the Blood-Brain Barrier Using Nanoparticles
Learn how MSK researchers are investigating the use of nanoparticles to carry drugs across the blood-brain barrier.
MSK researchers Kayvan Keshari, PhD, and Daniel Heller, PhD
MSK’s New Cancer Engineering PhD Program Is First of Its Kind
Learn about MSK’s visionary new cancer engineering PhD Program.
Students in the Cancer Engineering program will advance their research with support from state-of-the art core facilities including the Radiochemistry and Molecular Imaging Probes core.
Memorial Sloan Kettering Cancer Center’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences Announces First-of-Its-Kind Cancer Engineering PhD Program
The Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) at Memorial Sloan Kettering Cancer Center (MSK) today announced The Pat and Ian Cook Doctoral Program in Cancer Engineering, made possible by a generous gift of $15 million from Pat and Ian Cook.
Mijin Kim seen working in laboratory.
Advice From a ‘Wunderkind’: Why MSK Is Great for Early Career Researchers
Learn why post-doctoral researcher Mijin Kim believes Memorial Sloan Kettering is an excellent choice for early career biomedical researchers, as she enjoys her recognition as a STAT Wunderkind, class of 2023.
Dan Heller
A Sensor Sniffs for Cancer, Using Artificial Intelligence
By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.
Man holding an IUD
To Detect Ovarian Cancer Early, Researchers Look to Nanotechnology
Could an implantable IUD help detect cancer early, when it is most curable? Scientists at the Sloan Kettering Institute are betting yes.
In the News
an illustration of cancer metastasis
AACR 2019 Research Roundup: Nanosensors for Cancer, New Immunotherapy Targets, a Road Map of Metastasis, and CAR T Fratricide
Read our key takeaways from the second half of the American Association for Cancer Research’s 2019 annual meeting.
In the Lab
Two abstract paintings, one in color and one in black and white.
Science Meets Art to Build a Paintable Diagnostic Test for Cancer
A collaboration between a nanotechnology scientist and a visual artist leads to a promising diagnostic test and a new art form.
In the Lab
Medical illustration of nanoparticle spheres attacking cancer cell, which is beginning to disintegrate.
Nanoparticles Help Drugs Target Head and Neck Cancers with Reduced Side Effects
Researchers devised a novel method to ferry drugs to head and neck cancers using nanoparticles that naturally stick to a protein in tumor blood vessels.
In the Lab
Wearable device on woman’s arm with labels indicating beams going into nanotubes and coming back out for analysis.
Detective Work: How Implantable Nanosensors Could Monitor Cancer Activity
Learn how tiny sensors made of nanotubes could serve as implantable devices that offer a noninvasive way to monitor cancer and its treatments.
In the Lab
Metastatic tumor in the lung, with different colors used to represent the cell nuclei, the blood vessels, and the P-selectin protein.
Hacking Metastasis: Nanotechnology Researchers Find New Way to Target Tumors
A protein in blood vessels that plays a role in cancer metastasis is a promising target for delivering cancer drugs to tumors using nanoparticles.
MSK Researchers Hack the Metastatic Process Using Nanoparticles
Memorial Sloan Kettering Cancer Center (MSK) molecular pharmacologist Daniel Heller, PhD, and colleagues have identified a new strategy to target drugs specifically to cancer sites, including metastatic tumors. The approach involves nanoparticles designed to mimic a mechanism that tumors themselves use to metastasize throughout the body. This work, which will be featured on the cover of the June 29 issue of Science Translational Medicine, was applicable across a wide range of tumor and drug types and can potentially be applied to other conditions including vascular and autoimmune diseases.
Snapshot
Cellular sphere that is purple and lit throughout by yellow-orange light.
The Inner Light: Nanotechnology Reveals Density of Tumors
MSK <a href="/node/38885">nanotechnology</a> researchers have developed an innovative approach for measuring the permeability of living tumors.
In the Lab
Proximal tubule of the kidney.
Miniature Device Could Unlock the Promise of Some Kidney Cancer Drugs
Memorial Sloan Kettering scientists have engineered a tiny particle that could ferry drugs directly to the kidneys and prevent their uptake in other organs.
Announcement
Pictured: Jason Lewis, Anna-Katerina Hadjantonakis & Daniel Heller
Memorial Sloan Kettering Launches New Center for Molecular Imaging and Nanotechnology
The new center brings together scientists and clinicians working in various fields who will use the power of imaging to speed research and innovations in cancer care.
Video
Pictured: Daniel Heller
Tiny Solutions for Big Problems: A Visit to the Lab of Daniel Heller
Learn about Daniel Heller, who creates new nanoscale materials that are specially designed to improve biological research or solve clinical problems.
Event
A student asks a question at last year’s "Major Trends” seminar.
A Sneak Preview of Our Annual “Major Trends” Seminar Live Webcast
Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.